(*) CA Approval Date: 2022. 05.24
(*) USA Approval Year: 2017
>alpha-2 adrenergic receptor agonis
Company
Generic Name: Brimonidine
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2022. 07.05
RTM
RTM Web-Site